Mercado Global de Medicamentos PEGuilados – Tendências da Indústria e Previsão para 2028

Análise e insights de mercado: Mercado global de medicamentos PEGuilados

Espera-se que o mercado de medicamentos PEGuilados ganhe crescimento de mercado no período de previsão de 2021 a 2028. A Data Bridge Market Research analisa o mercado para atingir um valor estimado de 8.358,17 milhões de dólares e crescer a um CAGR de 5, 48% no período de previsão acima referido. O aumento dos gastos em investigação e desenvolvimento impulsiona o mercado de medicamentos PEGuilados.

A PEGuilação é um tipo de processo referido como ligação covalente e não covalente de cadeias poliméricas de polietilenoglicol a moléculas bioativas. É uma técnica muito promissora que auxilia no aumento da eficácia terapêutica dos medicamentos em ambiente clínico. Numerosos medicamentos PEGuilados foram aprovados pela Food and Drug Administration (FDA) e muitos medicamentos estão a ser testados em ambientes clínicos.

O aumento do crescimento no setor biológico para impulsionar os medicamentos PEGuilados é o fator vital que aumenta o crescimento do mercado, também aumenta a adoção de medicamentos à base de proteínas em vez de medicamentos não à base de proteínas, aumentando a estabilidade da proteína nos medicamentos , o aumento da taxa de prevalência de doenças do estilo de vida , o aumento da ocorrência de cancro, o aumento dos gastos em saúde devido ao aumento do rendimento disponível e o aumento do número de hospitais e clínicas em todo o mundo são os principais fatores, entre outros, que impulsionam o mercado dos medicamentos PEGuilados. Além disso, o aumento das oportunidades nos mercados emergentes e o aumento dos medicamentos biológicos mais vendidos que perderão a patente num futuro próximo criarão ainda mais novas oportunidades para o mercado de medicamentos PEGuilados no período previsto de 2021-2028.

No entanto, o aumento das reações adversas associadas aos medicamentos PEGuilados e às recolhas de medicamentos são os principais fatores, entre outros, que irão obstruir o crescimento do mercado e desafiar ainda mais o crescimento do mercado de medicamentos PEGuilados no período de previsão acima mencionado.

This PEGylated drugs market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on PEGylated drugs market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

PEGylated Drugs Market Scope and Market Size

PEGylated drugs market is segmented on the basis of molecule, type, and disease indication, application and sales channel. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.

• On the basis of molecule, the PEGylated drugs market is segmented into protein, FAB’ fragment, enzyme and aptamer.
• Based on type, the PEGylated drugs market is segmented into interferons, colony stimulating factors, monoclonal antibodies (mAbs) and other types.
• Based on disease indication, the PEGylated drugs market is segmented into gastrointestinal disorders, cancer, multiple sclerosis, hepatitis and other disease indications.
• Based on application, the PEGylated drugs market is segmented into cancer, autoimmune disease, hepatitis, multiple sclerosis, hemophilia, gastrointestinal disorder, and others.
• The PEGylated drugs market is also segmented on the basis of sales channel into hospital pharmacy, online provider and retail pharmacy.

Global PEGylated Drugs Market Country Level Analysis

PEGylated drugs market is analysed and market size insights and trends are provided by molecule, type, disease indication, application and sales channel as referenced above.

The countries covered in the PEGylated drugs market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the PEGylated drugs market due to rising prevalence of cancer along with advancements in the field of cancer research and rising usage of advanced drug delivery systems with PEGylation technology in this region. Europe is the second largest region in terms of growth in PEGylated drugs market due to increasing efforts by the government to reduce chronic disease burden due to the rising occurrence of cancer in the region.

The country section of the PEGylated drugs market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Healthcare Infrastructure growth Installed base and New Technology Penetration

PEGylated drugs market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment’s, installed base of different kind of products for PEGylated drugs market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the PEGylated drugs market. The data is available for historic period 2010 to 2019.

Competitive Landscape and PEGylated Drugs Market Share Analysis

PEGylated drugs market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to PEGylated drugs market.

Os principais players abrangidos no relatório do mercado de medicamentos PEGuilados são a Enzon Pharmaceuticals, Inc, F. Hoffmann-La Roche Ltd, Takeda Pharmaceutical Company Limited, Affymax, Inc, Novo Nordisk A/S, Biogen, Amgen Inc, Pfizer Inc, Teva Pharmaceutical Industries Ltd, Merck & Co., Inc, AstraZeneca, Nektar, Leadiant Biosciences, Inc, UCB SA, Horizon Therapeutics plc, Eiger BioPharmaceuticals, Halozyme, Inc, Biocad, PharmaEssentia Corporation, Novo Nordisk A/S e Bayer AG, entre outras empresas nacionais e globais players. Os dados de quota de mercado estão disponíveis para a Global, América do Norte, Europa, Ásia-Pacífico (APAC), Médio Oriente e África (MEA) e América do Sul em separado. Os analistas DBMR compreendem os pontos fortes competitivos e fornecem análises competitivas para cada concorrente em separado.

SKU-58869